Starpharma Is An Australian Biotechnology Company Based In Melbournespecializing In Dendrimer Nanotechnology For Pharmaceutical And Life Science Applicationswith Over Two Decades Of Experiencethe Company Focuses On Developing Innovative Therapeuticsparticularly In Oncology And Infectious Diseases The Core Of Starpharma S Work Is Its Proprietary Depa Dendrimer Enhanced Productsplatformwhich Enhances Drug Delivery And Therapeutic Efficacythe Company Offers A Range Of Productsincluding Depadrug Candidates For Cancer Therapythe Commercialized Vivagelabv For Bacterial Vaginosis Preventionand The Antiviral Nasal Spray Viralezea Approved In Malaysia In 2023Starpharma Collaborates With Pharmaceutical Companies And Research Institutions To Advance Its Technology And Has Co Founded Petalion Therapeutics To Explore New Therapeutic Avenues Starpharma Is Committed To Innovation And Collaborationaiming To Improve Patient Outcomes Through Its Advanced Nanotechnology And Strategic Partnershipswith A Specialized Team Of Around 50 Employeesthe Company Is Positioned As A Leader In Dendrimer Based Therapeutics
United Arab Emirates
